Centessa Pharmaceuticals plc — Director's Dealing 2024

Jun 27, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Centessa Pharmaceuticals plc (CNTA)
CIK: 0001847903
Period of Report: 2024-06-25

Reporting Person: Kulkarni Samarth (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-25	Share Option (right to buy)	$8.89	A	48000	Acquired	2034-06-25	Ordinary Shares (48000)	Direct

Footnotes

F1: The shares subject to such option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of shareholders, subject to continued service as a director through the applicable vesting date.

F2: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.